Wall Street analysts predict that Healthequity Inc (NASDAQ:HQY) will report $0.06 earnings per share for the current quarter, Zacks reports. Eight analysts have provided estimates for Healthequity’s earnings, with the highest EPS estimate coming in at $0.11 and the lowest estimate coming in at $0.04. Healthequity reported earnings per share of $0.07 in the same quarter last year, which would suggest a negative year over year growth rate of 14.3%. The firm is scheduled to announce its next quarterly earnings results after the market closes on Tuesday, February 6th.

On average, analysts expect that Healthequity will report full year earnings of $0.72 per share for the current year, with EPS estimates ranging from $0.68 to $0.74. For the next financial year, analysts forecast that the business will report earnings of $0.76 per share, with EPS estimates ranging from $0.68 to $0.90. Zacks’ earnings per share averages are a mean average based on a survey of sell-side research firms that that provide coverage for Healthequity.

Healthequity (NASDAQ:HQY) last released its earnings results on Tuesday, December 5th. The company reported $0.17 earnings per share for the quarter, beating the consensus estimate of $0.13 by $0.04. The company had revenue of $56.80 million during the quarter, compared to the consensus estimate of $55.27 million. Healthequity had a return on equity of 14.47% and a net margin of 21.08%. Healthequity’s revenue was up 31.0% compared to the same quarter last year. During the same period in the previous year, the company posted $0.10 EPS.

HQY has been the subject of several research reports. Zacks Investment Research raised Healthequity from a “hold” rating to a “buy” rating and set a $58.00 target price for the company in a research report on Wednesday, October 11th. BidaskClub raised Healthequity from a “sell” rating to a “hold” rating in a research note on Friday, December 22nd. Cantor Fitzgerald reaffirmed a “buy” rating and set a $56.00 price objective on shares of Healthequity in a research note on Tuesday, December 5th. Citigroup assumed coverage on Healthequity in a research note on Thursday, January 4th. They set a “buy” rating on the stock. Finally, JPMorgan Chase & Co. decreased their price objective on Healthequity from $52.00 to $51.00 and set an “overweight” rating on the stock in a research note on Wednesday, January 24th. Three analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $57.17.

Healthequity (NASDAQ:HQY) traded up $0.11 during midday trading on Monday, reaching $50.04. The company’s stock had a trading volume of 251,194 shares, compared to its average volume of 451,871. The firm has a market cap of $3,121.61, a P/E ratio of 67.47, a P/E/G ratio of 1.99 and a beta of 1.70. Healthequity has a 52 week low of $37.62 and a 52 week high of $55.31.

In related news, Director Frank Medici sold 13,000 shares of the stock in a transaction dated Wednesday, November 29th. The stock was sold at an average price of $52.14, for a total transaction of $677,820.00. Following the transaction, the director now directly owns 6,381 shares in the company, valued at $332,705.34. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Delano Ladd sold 26,405 shares of the stock in a transaction dated Tuesday, December 12th. The stock was sold at an average price of $43.32, for a total value of $1,143,864.60. Following the transaction, the executive vice president now owns 16,692 shares in the company, valued at $723,097.44. The disclosure for this sale can be found here. Insiders have sold 371,426 shares of company stock worth $18,749,703 over the last quarter. 29.00% of the stock is currently owned by company insiders.

Institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its position in shares of Healthequity by 3.0% during the 2nd quarter. Vanguard Group Inc. now owns 4,237,298 shares of the company’s stock worth $211,145,000 after purchasing an additional 122,061 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in Healthequity by 25.3% in the second quarter. Dimensional Fund Advisors LP now owns 473,433 shares of the company’s stock worth $23,591,000 after buying an additional 95,514 shares during the last quarter. Royal Bank of Canada raised its holdings in Healthequity by 42.9% in the second quarter. Royal Bank of Canada now owns 263,778 shares of the company’s stock worth $13,145,000 after buying an additional 79,144 shares during the last quarter. New York State Teachers Retirement System raised its holdings in Healthequity by 8.0% in the third quarter. New York State Teachers Retirement System now owns 33,651 shares of the company’s stock worth $1,702,000 after buying an additional 2,500 shares during the last quarter. Finally, Janus Henderson Group PLC raised its holdings in Healthequity by 627.9% in the second quarter. Janus Henderson Group PLC now owns 2,113,030 shares of the company’s stock worth $105,292,000 after buying an additional 1,822,732 shares during the last quarter. Institutional investors own 98.20% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Healthequity Inc (HQY) Expected to Announce Earnings of $0.06 Per Share” was posted by Watch List News and is owned by of Watch List News. If you are viewing this report on another site, it was illegally copied and republished in violation of United States and international copyright & trademark legislation. The correct version of this report can be read at https://www.watchlistnews.com/healthequity-inc-hqy-expected-to-announce-earnings-of-0-06-per-share/1852663.html.

Healthequity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Get a free copy of the Zacks research report on Healthequity (HQY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.